Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.

Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys ...

The late Steve Jobs’s son set up a VC firm that backs startups and researchers working on cancer treatments. Now his Yosemite ...

A Longfellow resident built his new home with a dedicated art studio to hold his loom and combined midcentury modern and ...

As a researcher, I still remember the discomfort I felt every time I had to sacrifice laboratory animals for an experiment.

Breast cancer isn't just a 'pink' disease; for men with a family history or genetic predisposition, a mammogram can be a ...

CytomX Therapeutics Inc (CTMX) reports encouraging results from its Varseta-M study, with plans for a pivotal trial and expansion into new tumor types.

A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Scientists at the University of Science and Technology of China have identified a signaling chain that starts with gut ...